Dr. Kyle Rohde

Burnett School of Biomedical Sciences, University of Central Florida

The Discovery of New Tuberculosis Drugs From Natural Compounds

In this video, Dr. Kyle Rohde, associate professor at the University of Central Florida, discusses his lab's work to find the next generation of antibiotic treatments for tuberculosis (TB). This is achieved by testing natural compounds that may have antibiotic activity as well as looking at known TB drugs to make them more effective. Here, Rohde explains how the Integra ASSIST PLUS system addresses the liquid handling challenges faced when setting up drug plates. Rohde highlights the small footprint, the affordability, and the user-friendly interface as features that make the ASSIST PLUS the ideal instrument for his laboratory's needs.



LIKE 1
Dr. Kyle Rohde
Health Sciences

Dr. Kyle Rohde

Biography

Kyle Rohde is Associate Professor at UCF. His work focuses on the understanding of TB pathogenesis. More

Dr. Kyle Rohde

Burnett School of Biomedical Sciences, University of Central Florida

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (Mtb), infects ~9 million new people and claims ~1.5 million lives each year. This ongoing global health crisis stems from the lack of an effective vaccine, inadequate diagnostics and drug regimens, emergence of multi-drug resistant strains, and synergism with HIV infection. Thus, there is an urgent need to better understand how Mtb causes disease in order to develop reliable diagnostics, protective vaccines, and fast-acting drugs effective against Mtb. By taking a multifaceted approach Rohde hopes to improve understanding of this disease and add to the arsenal of tools aimed at this pathogen, we hope to make a significant contribution to the fight against TB.